Patent ID: 11911473
Assignee: AZURITY PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 18:
19. The method of claim 1, wherein the liquid diluent consisting essentially of:
0.5%-4.0% w/v of the poloxamer;
1.0%-5.0% w/v of the suspending agent, wherein the suspending agent is (i) sodium carboxymethylcellulose (CMC) or (ii) a combination of sodium CMC and microcrystalline cellulose;
4.0%-20% w/v of sodium bicarbonate;
0.1%-0.3% w/v of simethicone emulsion;
0.2%-1.2% w/v of the preservative;
water;
a buffering agent, wherein the buffering agent maintains a pH of 8 to 9.5;
a sweetener; and
optionally one or more excipients selected from a coloring agent and a flavoring agent;
wherein the liquid diluent is stable for at least 30 days at 5±3° C. and is resistant to gel formation for at least one freeze-thaw cycle.